| Nanette A Ballard, MD | |
|
1225 N State St, Jackson, MS 39202-2064 | |
| (601) 968-3070 | |
| (601) 974-6286 |
| Full Name | Nanette A Ballard |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 36 Years |
| Location | 1225 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356367312 | NPI | - | NPPES |
| 00118964 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 12147 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Of Central Mississippi Inc | 1153216411 | 233 |
News Archive
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.
Loren Becker, manager of the Global Health Technologies Coalition's (GHTC) Global Health Regulatory Team, discusses the new East African Community's (EAC) Medicines Regulatory Harmonization initiative, launched at the end of March in Arusha, Tanzania, in this post in GHTC's "Breakthroughs" blog.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
More than 50 companies involved in global development work have formed the Coalition of International Development Companies "in hopes of gaining more visibility for their work with the U.S. Agency for International Development as well as with other government agencies and nongovernmental organizations," Washington Technology reports.
› Verified 3 days ago
| Entity Name | Ms Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649238882 PECOS PAC ID: 8820991045 Enrollment ID: O20040127000805 |
News Archive
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.
Loren Becker, manager of the Global Health Technologies Coalition's (GHTC) Global Health Regulatory Team, discusses the new East African Community's (EAC) Medicines Regulatory Harmonization initiative, launched at the end of March in Arusha, Tanzania, in this post in GHTC's "Breakthroughs" blog.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
More than 50 companies involved in global development work have formed the Coalition of International Development Companies "in hopes of gaining more visibility for their work with the U.S. Agency for International Development as well as with other government agencies and nongovernmental organizations," Washington Technology reports.
› Verified 3 days ago
| Entity Name | Medical Foundation Of Central Mississippi Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992774814 PECOS PAC ID: 1153216411 Enrollment ID: O20040217000380 |
News Archive
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.
Loren Becker, manager of the Global Health Technologies Coalition's (GHTC) Global Health Regulatory Team, discusses the new East African Community's (EAC) Medicines Regulatory Harmonization initiative, launched at the end of March in Arusha, Tanzania, in this post in GHTC's "Breakthroughs" blog.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
More than 50 companies involved in global development work have formed the Coalition of International Development Companies "in hopes of gaining more visibility for their work with the U.S. Agency for International Development as well as with other government agencies and nongovernmental organizations," Washington Technology reports.
› Verified 3 days ago
| Entity Name | Mississippi Baptist Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467589556 PECOS PAC ID: 9234026600 Enrollment ID: O20110707000181 |
News Archive
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.
Loren Becker, manager of the Global Health Technologies Coalition's (GHTC) Global Health Regulatory Team, discusses the new East African Community's (EAC) Medicines Regulatory Harmonization initiative, launched at the end of March in Arusha, Tanzania, in this post in GHTC's "Breakthroughs" blog.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
More than 50 companies involved in global development work have formed the Coalition of International Development Companies "in hopes of gaining more visibility for their work with the U.S. Agency for International Development as well as with other government agencies and nongovernmental organizations," Washington Technology reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nanette A Ballard, MD Po Box 2121, Memphis, TN 38159-0001 Ph: (601) 968-3070 | Nanette A Ballard, MD 1225 N State St, Jackson, MS 39202-2064 Ph: (601) 968-3070 |
News Archive
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.
Loren Becker, manager of the Global Health Technologies Coalition's (GHTC) Global Health Regulatory Team, discusses the new East African Community's (EAC) Medicines Regulatory Harmonization initiative, launched at the end of March in Arusha, Tanzania, in this post in GHTC's "Breakthroughs" blog.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
More than 50 companies involved in global development work have formed the Coalition of International Development Companies "in hopes of gaining more visibility for their work with the U.S. Agency for International Development as well as with other government agencies and nongovernmental organizations," Washington Technology reports.
› Verified 3 days ago
Sawsan Faroussi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1530 Fax: 601-984-1531 | |
Kathryn B Brown, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1225 N State St, Jackson, MS 39202 Phone: 601-968-3070 Fax: 601-974-6286 | |
Jack Roy Lewin, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1530 Fax: 601-984-1531 | |
Jennifer S Schulmeier, MD Pathology Medicare: Medicare Enrolled Practice Location: 3120 Old Canton Rd, Jackson, MS 39216 Phone: 601-362-9851 Fax: 601-982-9025 | |
Dr. Alexander Vortmeyer, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1530 Fax: 601-984-1531 | |
Dr. Volney E Pierce, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Dept Of Pathology, Jackson, MS 39216 Phone: 601-984-6426 Fax: 601-984-6439 | |
Elizabeth Rhyne Flowers, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1530 Fax: 601-984-1531 |